Abstract:Cancer ranks as one of the deadliest diseases worldwide. The high mortality rate associated with cancer is partially due to the lack of reliable early detection methods and/or inaccurate diagnostic tools such as certain protein biomarkers. Cell-free nucleic acids (cfNA) such as circulating long non-coding RNAs (lncRNAs) have recently been proposed as a new class of potential biomarkers that could improve cancer diagnosis. The reported correlation between circulating lncRNA levels and the presence of tumors has triggered a great amount of interest among clinicians and scientists who have been actively investigating their potentials as reliable cancer biomarkers. In this report, we review the progress achieved (the Good) and challenges encountered (the Bad) in the development of circulating lncRNAs as potential biomarkers for early cancer diagnosis. We report and discuss the specificity and sensitivity issues of blood-based lncRNAs currently considered as promising biomarkers for various cancers such as hepatocellular carcinoma, colorectal cancer, gastric cancer and prostate cancer. We also emphasize the potential clinical applications (the Beauty) of circulating lncRNAs both as therapeutic targets and agents, on top of diagnostic and prognostic capabilities. Based on different published works, we finally provide recommendations for investigators who seek to investigate and compare the levels of circulating lncRNAs in the blood of cancer patients compared to healthy subjects by RT-qPCR or Next Generation Sequencing.

Circulating Long Noncoding RNAs As Novel Biomarkers of Human Diseases

Long non‑coding RNAs: novel links in respiratory diseases (review).

Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics.

Circulating Long Non-Coding RNAs in Cancer: Current Status and Future Perspectives

Circulating Circular RNAs As Biomarkers of Cancer

Circular RNAs as Biomarkers for Cancer.

Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.

Long Non-Coding RNAs: a New Frontier in the Study of Human Diseases.

Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty

Long non-coding RNAs: The novel diagnostic biomarkers for leukemia

Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy

Mysterious long noncoding RNAs and their relationships to human disease

Circulating non-coding RNAs as new biomarkers and novel therapeutic targets in colorectal cancer

Circular RNAs: a Novel Tool in the Development of Digestive System Biomarker

Circulating microRNAs: Biomarkers of disease

Long Non-Coding Rnas in Non-Small Cell Lung Cancer As Biomarkers and Therapeutic Targets

Exosomal RNAs: Novel Potential Biomarkers for Diseases—A Review

Blood-derived lncRNAs as potential biomarkers for early cancer diagnosis: The Good, the Bad and the Beauty

Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and Prospects

Long Noncoding RNA 00472: A Novel Biomarker in Human Diseases

Long Non-Coding RNAs and Complex Human Diseases